Skip to main content
. 2014 Mar 21;4(4):177–191. doi: 10.4161/trns.25558

Table 4. Pathways downregulated following miR-190 expression.

Interferon response interferon-inducible genes upregulated in lung cancer infected with RSV
Response to Imiquimod interferon cluster genes upregulated in skin tumors treated with Imiquimod
Response to IFNG (up) genes upregulated in five primary endothelial cell types by IFNG
Response to IFNA1 (up) genes upregulated in primary hepatocyte in response to IFNA
ILF3 targets (up) upregulated in osteosarcoma upon ectopic expression of ILF3
IFN α response (up) genes upregulated in fibrosarcoma by treatment with INF α
Interferon responsive genes genes upregulated in primary fibroblast culture after treatment with INF α
Response to radiation therapy genes upregulated in response to both single dose and fractionated radiation
Silenced by deacetylation genes upregulated in pancreatic cancer cell lines by TSA
Breast cancer amplicon genes within amplicon 7p22 with a copy number alterations in breast tumors
Regulated by methylation genes upregulated in pancreatic cancer after treatment with decitabine
Liver cancer ACOXI (up) genes upregulated in hepatocellular carcinoma of ACOX1 knockout mice
UV response via ERCC3 genes upregulated in fibroblasts expressing mutant forms of ERCC3 after UV IR
ERCC3 allele XPCS vs. TTD genes upregulated in fibroblasts expressing different mutant forms of ERCC3
Stromal stimulation (up) genes upregulated in multiple myeloma cells co-cultured with stromal cells
Liver cancer subclass G3 (down) downregulated genes in hepatocellular carcinoma (HCC) subclass G3
Graft-vs.-host disease genes involved in graft-vs.-host disease
Antigen processing and presentation genes involved in antigen processing and presentation
Allograft rejection genes involved in allograft rejection